Chromogranin A (CGA) is a protein that is stored and released together with neurotransmitters and hormones in the nervous, endocrine and diffuse neuroendocrine systems. As human vasostatins I and II [CGA(1–76) and CGA(1–113), respectively] have been reported to affect vessel motility and exert concentration‐dependent cardiosuppressive effects on isolated whole heart preparations of eel, frog and rat (i.e. negative inotropism and antiadrenergic activity), we investigated the presence of vasostatin‐containing peptides in rat heart. Rat heart extracts were purified by RP‐HPLC, and the resulting fractions analyzed for the presence of CGA N‐terminal fragments using dot‐blot analysis. CGA‐immunoreactive fractions were submitted to western blot and MS analysis using the TOF/TOF technique. Four endogenous N‐terminal CGA‐derived peptides [CGA(4–113), CGA(1–124), CGA(1–135) and CGA(1–199)] containing the vasostatin sequence were characterized. The following post‐translational modifications of these fragments were identified: phosphorylation at Ser96, O‐glycosylation (trisaccharide, NAcGal‐Gal‐NeuAc) at Thr126, and oxidation at three methionine residues. This first identification of CGA‐derived peptides containing the vasostatin motif in rat heart supports their role in cardiac physiology by an autocrine/paracrine mechanism.